Evidence map›Paper›PMID 28882893›Full record

ArticleThe Journal of biological chemistry2017

Kinetic signatures of myosin-5B, the motor involved in microvillus inclusion disease.

Sarah M Heissler, Krishna Chinthalapudi, James R Sellers

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. International journal of molecular sciences · 2022
    Article
  5. Article
  6. Roles and regulation of myosin V interaction with cargo.Advances in biological regulation · 2021
    Review
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Sarah M HeisslerFrom the Laboratory of Molecular Physiology, NHLBI, National Institutes of Health, Bethesda, Maryland 20892-8015 and sarah.heissler@nih.gov.
Krishna Chinthalapudithe Cell Adhesion Laboratory, Department of Integrative Structural and Computational Biology, Scripps Research Institute, Jupiter, Florida 33458.
James R SellersFrom the Laboratory of Molecular Physiology, NHLBI, National Institutes of Health, Bethesda, Maryland 20892-8015 and sellersj@nhlbi.nih.gov.
National Institutes of Health · USScripps Research Institute · US

Funding

Expression Studies of Other Unconventional MyosinsZIAHL004232 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI SELLERS, JAMES · 2009 to 2025
$11.7M
Studies Of Myosin VZ01HL004229 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI SELLERS, JAMES R. · 1997 to 2008
$1.1M
MAKAP FUNCTIONS OF A PKA ANCHORING PROTEINK08HL004229 · NHLBI · OREGON HEALTH AND SCIENCE UNIVERSITY · PI KAPILOFF, MICHAEL SETH · 2000 to 2004
$635k
Intramural NIH HHS Z01 HL004229NHLBI NIH HHS K08 HL004229
6 · The paper itself

Abstract

Myosin-5B is a ubiquitous molecular motor that transports cargo vesicles of the endomembrane system in intracellular recycling pathways. Myosin-5B malfunction causes the congenital enteropathy microvillus inclusion disease, underlining its importance in cellular homeostasis. Here we describe the interaction of myosin-5B with F-actin, nucleotides, and the pyrazolopyrimidine compound myoVin-1. We show that single-headed myosin-5B is an intermediate duty ratio motor with a kinetic ATPase cycle that is rate-limited by the release of phosphate. The presence of a second head generates strain and gating in the myosin-5B dimer that alters the kinetic signature by reducing the actin-activated ADP release rate to become rate-limiting. This kinetic transition into a high-duty ratio motor is a prerequisite for the proposed transport function of myosin-5B in cellular recycling pathways. Moreover, we show that the small molecule compound myoVin-1 inhibits the enzymatic and functional activity of myosin-5B

Indexed as

Models, MolecularActin CytoskeletonAmino Acid SubstitutionBinding SitesComputational BiologyDimerizationEnzyme InhibitorsExpert SystemsHumansKineticsMalabsorption SyndromesMicrovilliMolecular Docking SimulationMucolipidosesMutationMyosin Heavy ChainsEnzyme InhibitorsMYO5B protein, humanMyo5B protein, mouseMyosin Heavy ChainsMyosin Type VmyoVin-1Peptide FragmentsPyrazolesPyrimidinesactinATPaseinhibitorkineticsmyosinmyoVin-1

Identifiers

PMID28882893
PMCPMC5672057
OpenAlexW2750886524

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.